Y-mAbs Therapeutics News

Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gad Thomas

May 24 06:56

Y-mAbs Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 22 04:46

Y-mAbs Therapeutics | 10-Q: Quarterly report

May 8 04:22

Y-mAbs Therapeutics | 8-K: Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments

May 8 04:16

Y-mAbs Therapeutics | 8-K: Current report

Apr 30 05:14

Y-mAbs Therapeutics | ARS: Annual Report to Security Holders

Apr 30 05:11

Y-mAbs Therapeutics | DEFA14A: Others

Apr 30 05:09

Y-mAbs Therapeutics | DEF 14A: Definitive information statements

Apr 30 04:07

Y-mAbs Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals

Apr 9 05:13

Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director TAGLIAFERRI MARY

Mar 15 05:06

Y-mAbs Therapeutics | 8-K: Current report

Mar 14 21:19

Y-mAbs Therapeutics | 3: Initial statement of beneficial ownership of securities-Director TAGLIAFERRI MARY

Mar 8 19:20

Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gad Thomas

Mar 8 06:07

Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rajah Vignesh

Mar 8 06:07

Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Smith Susan Laura

Mar 8 06:01

Y-mAbs Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 7 05:51

Y-mAbs Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 7 05:45

Y-mAbs Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 6 08:10

Y-mAbs Therapeutics | 8-K: Current report

Mar 4 19:10

Y-mAbs Therapeutics | 10-K: Annual report

Mar 1 11:38